Since the late 1980s there have been a number of reports about the complications associated with using the designer drug 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasyl\ -3. Although this drug has been widely abused in the past, the potentially fatal complications have arisen recently mainly due to the circumstances of its use at all-night dance sessions or 'raves'. A combination of direct toxicity and strenuous physical exertion can lead to hyperthermia and its attendant complications. The following case illustrates some of the possible consequences following ingestion of 'ecstasy', and reiterates the importance of prompt recognition and treatment in preventing the development of irreversible sequelae.
CASE HISTORY
An IS-year-old previously fit young woman was admitted to casualty having taken one tablet of 'ecstasy' purchased at a local night club. She had vomited several times, complained of cramps in her legs and had visual hallucinations. There was no history of regular drug abuse: this was the first time she had taken ecstasy. She had been treated with the serotonin reuptake inhibitor, fluoxetine for an episode of depression 8 months prior to admission with no ill effects. On examination she was sweaty, agitated and tremulous with a rectal temperature of 40.3°e. She was hypotensive, IOOl60mmHg and had a tachycardia of 140/min. Her pupils were dilated, and she was noted to have brisk tendon reflexes.
Initial investigations revealed renal impairment, urea 9.7 mmolll and creatinine 204 Jlmoll!. At this point her creatine kinase was 226 il/l (reference range 180 u/l), Soon after admission her temperature rose to 43°e. She was given dantrolene (I mg/kg) intravenously and cold sponged in order to reduce her hyperthermia. A grand mal convulsion was treated with Diazemuls. She was resuscitated with intravenous colloids, dextrose (plasma glucose 1.4mmolll), dopamine and dobutamine. On transfer to ITil she was intubated and ventilated. By 7 h post admission her temperature was 38°e, however she had developed disseminated intravascular coagulation (DIC) with increased fibrin degradation products and a falling platelet count (minimum 7 X 10 9/1). Progressive jaundice was noted from day 2, with a peak bilirubin of 435 Ilmolll, and ALT of 1523 ill!. Rhabdomyolysis was undoubtedly present as her creatine kinase rose to 170000 il/l, although a random urine was negative for myoglobin. Despite aggressive treatment with haemofiltration for oligouric renal failure, blood and blood products to correct the coagulopathy, and broad spectrum antibiotics, she suddenly deteriorated 8 days after admission and died the following day.
A toxicology screen showed urine positive for MDMA and its metabolite MDA (3,4-methylenedioxyamphetamine), serum was positive for MDA only, peak concentration 0.246 mg/!. Post mortem examination showed extensive hepatic necrosis with cholestasis and acute pancreatic necrosis. There was evidence of rhabdomyolysis present in skeletal muscle.
DISCUSSION
This case demonstrates the pattern of toxicity comprlsmg fulminant hyperthermia, renal failure, rhabdomyolysis and coagulopathy, which can occur after ingestion of MDMA associated with vigorous and prolonged dancing. The hepatotoxicity was unusual, in that it occurred acutely after just one tablet of ecstasy. Previous cases of serious liver dysfunction related to this drug, have tended to occur after chronic exposure over weeks or months. The aetiology of the fulminant liver failure is unclear. However, similar biochemical and gross pathological liver abnormalities have been seen in exertional heat stroke, a condition sharing many of the complications with ecstasy abuse in a dance settint. In this case there was no evidence of any other cause for the hepatotoxicity, in particular paracetamol overdose, or infection with hepatitis A, B or e.
It remains unclear why certain individuals in similar circumstances of MDMA ingestion succumb to the fatal sequence of events outlined above, while others escape such a scenario. Previous experience of the drug does not preclude a subsequent fatal reaction. In some cases there might be an underlying genetic predisposition to hyperthermia, similar to that seen in young, apparently fit individuals, who develop exertional heat stroke during 52P strenuous exercise. There are several other syndromes, which present with hyperthermia as the main clinical feature. These include neuroleptic malignant syndrome, malignant hyperthermia and serotonin syndrome.
MDMA alters thermoregulation by interfering with serotonin pathways: this hyperthermic effect is then compounded by the prolonged physical activity at all-night dance sessions. It is of interest that the patient described was treated with fluoxetine, as this has been implicated in causing the serotonin syndrome, when used in combination with other drugs (e.g. monoamine-oxidase inhibitors) which enhance central nervous system serotonin levels'. In common with other amphetamine related substances MDMA also affects dopamine, perhaps explaining some of the toxicity features this drug shares with the neuroleptic malignant syndrome caused by dopamine blocking drugs 6 . It seems likely, therefore, that the toxic effects of ecstasy arise from a combination of a direct effect on neurotransmitters, aggravated by prolonged drug stimulated exercise in susceptible individuals.
The important lessons to be learnt from this case are, first, the pattern of toxicity associated with ecstasy ingestion must be recognized promptly, so that measures to reduce the hyperthermia can be instituted rapidly. It is evident that the prognosis is considerably worsened once DIe has occurred, and this is more likely the longer the temperature remains above 40°C. Secondly, youngsters who attend 'raves' or night clubs where MDMA is available need to be aware of the possible consequences of taking the drug in circumstances that potentiate its hyperthermia-inducing properties. Measures to educate both potential abusers and the 'dance' organizers are already in place in certain areas, as reported in a recent article in the Guardian 7 . As long as the present 'rave culture' exists it is likely that deaths related to ecstasy will continue to occur in the future.
